Technical Analysis for MNK - Mallinckrodt plc

Grade Last Price % Change Price Change
grade C 4.75 13.91% 0.58
MNK closed up 13.91 percent on Tuesday, February 25, 2020, on 4.8 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Its advance stalled at its 200 day moving average, an important long-term support / resistance line.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
Historical MNK trend table...

Date Alert Name Type % Chg
200 DMA Resistance Bearish 0.00%
20 DMA Resistance Bearish 0.00%
Slingshot Bearish Bearish Swing Setup 0.00%
Crossed Above 50 DMA Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Earnings Movers Other 0.00%
Upper Bollinger Band Touch Strength 0.00%
Fell Below 20 DMA Bearish 13.91%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Mallinckrodt public limited company develops, manufactures, markets, and distributes branded and generic specialty pharmaceuticals, active pharmaceutical ingredients (API), and diagnostic imaging agents worldwide. The company's Specialty Pharmaceuticals segment offers EXALGO extended-release tablets to treat pain in opioid-tolerant patients; and GABLOFEN injections indicated for use in the management of spasticity of cerebral or spinal origin in patients age four years and above. This segment also provides generic drugs, such as oxycodone or in combination with acetaminophen, as well as hydrocodone, which in combination with acetaminophen to treat pain; and methylphenidate to treat attention deficit hyperactivity disorder. This segment markets its branded products to physicians, including pain specialists, anesthesiologists, orthopedic surgeons, rheumatologists, and neurologists; and generic products to wholesalers, large- and medium-sized retail pharmacy chains, food store chains with pharmacies, mail order pharmacies, and other channels of distribution. Its Global Medical Imaging segment provides contrast media and delivery systems comprising iodine- and gadolinium-containing injectable products for diagnostic imaging applications, such as computed tomography and magnetic resonance imaging under the Optiray and Optimark brand names. This segment also offers nuclear imaging agents consisting of Technescan MAG3, a nuclear imaging agent to detect and evaluate a range of renal disorders; technetium-99m for use in Ultra-Technekow DTE generators; cold kits; and other radiopharmaceuticals, such as Octreoscan to detect cancer. This segment sells its contrast media systems to hospitals and hospital groups; branded products directly to managed care organizations; and API products to other pharmaceutical companies. The company was incorporated in 2013 and is based in Dublin, Ireland. Mallinckrodt plc (NYSE:MNK) operates independently of Covidien plc as of June 28, 2013.
Medicine Cancer Physical Sciences Pharmaceutical Pain Natural Sciences Pharmaceutical Industry In China Medical Imaging Active Pharmaceutical Ingredients Diagnostic Imaging Medical Physics Magnetic Resonance Imaging Tomography Attention Deficit Hyperactivity Disorder Medicinal Radiochemistry Radiopharmaceuticals Contrast Media Covidien Generic Products Radiochemistry Renal Disorders

Is MNK a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 25.54
52 Week Low 1.43
Average Volume 8,218,082
200-Day Moving Average 5.29
50-Day Moving Average 4.34
20-Day Moving Average 4.91
10-Day Moving Average 4.86
Average True Range 0.72
ADX 28.53
+DI 26.12
-DI 32.32
Chandelier Exit (Long, 3 ATRs ) 4.03
Chandelier Exit (Short, 3 ATRs ) 4.68
Upper Bollinger Band 5.53
Lower Bollinger Band 4.28
Percent B (%b) 0.37
BandWidth 25.38
MACD Line 0.09
MACD Signal Line 0.18
MACD Histogram -0.0966
Fundamentals Value
Market Cap 460.92 Million
Num Shares 97 Million
EPS -4.63
Price-to-Earnings (P/E) Ratio -1.03
Price-to-Sales 0.92
Price-to-Book 0.59
PEG Ratio 0.79
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.17
Resistance 3 (R3) 7.38 6.78 6.76
Resistance 2 (R2) 6.78 6.17 6.68 6.63
Resistance 1 (R1) 5.77 5.79 5.47 5.56 6.49
Pivot Point 5.17 5.17 5.03 5.07 5.17
Support 1 (S1) 4.16 4.56 3.86 3.95 3.01
Support 2 (S2) 3.56 4.18 3.46 2.87
Support 3 (S3) 2.55 3.56 2.74
Support 4 (S4) 2.34